Figures computed from official regulatory filings — .
Ownershipinsiders 31.39% · institutions 13.81%
In EUR · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for GENOWAY only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.
Market information source · Oct 5, 2026
Open-market timeline · full history
15 buys19 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Alexandre Fraichardtrack record | Buy | $215.7K | conv 66 |
| AMF |
| Alexandre Fraichardtrack record | Buy | $101.7K | conv 53Unusual size | AMF |
| Alexandre Fraichardtrack record | Buy | $69.2K | conv 48First in 12mo | AMF |
| CARLYS SOCIETE CIVILE | Sell | $27.6K | AMF |
| SOLYS SARL | Sell | $13.5K | AMF |
| SOLYS SARL | Buy | $14K | conv 54First in 12mo | AMF |
| ISTYA FOND DE DOTATION | Sell | $13.4K | AMF |
| JEAN LOUIS MENARD | Sell | $11.3K | AMF |
| JEAN LOUIS MENARD | Buy | $106.1K | conv 54First in 12mo | AMF |
| olivier Charmeil | Award | $117.2K | AMF |
| Florent Pons | Buy | $1.6K | conv 79First in 12mo | AMF |
| Florent Pons | Buy | $1.5K | conv 53 | AMF |
| Alexandre Fraichardtrack record | Buy | $37.4K | conv 35 | AMF |
| Alexandre Fraichardtrack record | Buy | $39.6K | conv 59First in 12mo | AMF |
| Florent Pons | Sell | $16.8K | Unusual size | AMF |
| Florent Pons | Sell | $8.9K | Unusual size | AMF |
| Christian Grenier | Sell | $24K | AMF |
| Florent Pons | Sell | $2.3K | AMF |
| Florent Pons | Sell | $1.7K | AMF |
| Florent Pons | Sell | $2.9K | AMF |
| Christian Grenier | Buy | $21.2K | conv 58First in 12mo | AMF |
| Kader THIAM | Sell | $171.4K | AMF |
| olivier Charmeil | Buy | $326.3K | conv 43First in 12mo | AMF |
| FINOWAY SAS | Sell | $81.5K | AMF |
| FINOWAY SAS | Sell | $242.3K | AMF |